Unimed Pharmaceuticals Incorporated

Unimed Pharmaceuticals Incorporated develops and markets prescription pharmaceutical products. Unimed Pharmaceuticals strategy is to establish a leading position within specialty pharmaceutical markets. Unimed Pharmaceuticals expects to build a diversified portfolio of products in several therapeutic areas including HIV and other infectious diseases, endocrinology, hematology, oncology and urology. Currently, the Unimed Pharmaceuticals promotes three approved drugs for these markets: Marinol(R) (dronabinol), an appetite stimulant and antiemetic drug, Maxaquin(R) (lomefloxacin), a fluoroquinolone anti-infective used in the urology and infectious disease markets, and Anadrol(R)(oxymetholone), an orally active anabolic androgenic steroid used to treat various anemias.

Contact Details: 2150 East Lake Cook Road Buffalo Grove IL 60089 United States of America Tel: 708 541 2525 Fax: 708 541 2533 Email:

Loading...

Recent Publications by Unimed Pharmaceuticals Incorporated:
Andropause: knowledge and perceptions among the general public and health care professionals. BACKGROUND: Andropause, the natural age-related decline in testosterone in...	7th February, 2003	Unimed Pharmaceuticals, Inc., Deerfield, Illinois, USA.	J Gerontol A Biol Sci Med Sci. 2002 Dec;57(12):M793-6.

BioNews Results for Unimed Pharmaceuticals Incorporated:
Poniard Pharmaceuticals to Host Conference Call and Webcast at 8:00 a.m. Eastern Time Tomorrow to Discuss Results of Pivotal Phase 3 SPEAR Trial in Small Cell Lung Cancer	FinanzNachrichten.de:  Nov 16 2009 12:34AM Matching: pharmaceuticals
Poniard Pharmaceuticals to Host Conference Call and Webcast at 8:00 a.m. Eastern Time Tomorrow to Discuss Resu	Dallas Business Chronicle:  Nov 16 2009 3:33AM Matching: pharmaceuticals
Poniard Pharmaceuticals to Host Conference Call and Webcast at 8:00 a.m. Eastern Time Tomorrow to Discuss Resu	Kansas City Business Journal:  Nov 16 2009 3:25AM Matching: pharmaceuticals
Poniard Pharmaceuticals to Host Conference Call and Webcast at 8:00 a.m. Eastern Time Tomorrow to Discuss Resu	South Florida Business Journal:  Nov 16 2009 3:23AM Matching: pharmaceuticals
Poniard Pharmaceuticals to Host Conference Call and Webcast at 8:00 a.m. Eastern Time Tomorrow to Discuss Resu	Washington Business Journal:  Nov 16 2009 1:25AM Matching: pharmaceuticals
Promote your company here: BioNewsCast - Press Release Distribution	→View more Unimed Pharmaceuticals Incorporated news.

Unimed Pharmaceuticals Incorporated Clinical Trials:
A Study of Nitazoxanide in the Treatment of AIDS-Related Diarrhea

Unimed Pharmaceuticals Incorporated Patents:
US Patent No.	Title
6747058	Stable composition for inhalation therapy comprising delta-9-tetrahydrocannabinol and semiaqueous solvent therefor
6703418	Appetite stimulation and induction of weight gain in patients suffering from symptomatic HIV infection
6503894	Pharmaceutical composition and method for treating hypogonadism
5804592	Method for improving disturbed behavior and elevating mood in humans

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 829 times since April 2007, the link to the organisation's website has been followed 0 times

Recent Search Terms used to find this page: unimed pharmaceuticals | UNIMED PHARMACEUticals 60089 | Unimed Pharmaceuticals Inc. Deerfield Illinois | unimed pharmaceuticals products | unimed pharma | unimed pharmaceutical products | UN | unimed | UNIMED PHARMACEUTICAL email | UNIMED Pharmaceuticals | .

Search for more companies in Buffalo Grove

Search for more companies in IL

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Unimed Pharmaceuticals Incorporated